Indivior (INDV)
(Real Time Quote from BATS)
$10.16 USD
-0.03 (-0.29%)
Updated Jul 10, 2024 02:18 PM ET
4-Sell of 5 4
B Value F Growth B Momentum D VGM
Indivior PLC (INDV) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$36.00 | $37.00 | $35.00 | 253.29% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for Indivior PLC comes to $36.00. The forecasts range from a low of $35.00 to a high of $37.00. The average price target represents an increase of 253.29% from the last closing price of $10.19.
Analyst Price Targets (2 )
Broker Rating
Indivior PLC currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on four recommendations.
Of the four recommendations deriving the current ABR, four are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/3/2024 | Craig-Hallum | Chase Knickerbocker | Not Available | Strong Buy |
2/16/2024 | Northland Capital Markets | Carl Byrnes | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 4 |
Average Target Price | $36.00 |
LT Growth Rate | NA |
Industry | Medical - Drugs |
Industry Rank by ABR | 154 of 252 |
Current Quarter EPS Est: | 0.38 |